• FirefoxInstall the new Firefox »
  •  Dow Down 0.45% Nasdaq Down 0.49%

    Novavax, Inc. (NVAX)

    -NasdaqGS
    9.15 Down 0.16(1.72%) 4:00PM EST
    |After Hours : 9.15 Down 0.00 (0.01%) 4:39PM EST - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:9.31
    Open:8.65
    Bid:9.03 x 1000
    Ask:9.15 x 400
    1y Target Est:9.58
    Beta:0.73
    Next Earnings Date:N/A
    Day's Range:8.51 - 9.25
    52wk Range:3.34 - 9.83
    Volume:5,261,303
    Avg Vol (3m):4,961,580
    Market Cap:2.18B
    P/E (ttm):N/A
    EPS (ttm):-0.30
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for NVAX

    Comparison

    Symbol% ChgMkt Cap
    NVAXDown 1.72%2.18B
    MRKDown 0.71%166.89B
    NVSDown 0.58%245.62B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):67.92
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.33
    Quarterly EPS Est (Mar-15) :-0.09
    Mean Recommendation*:1.4
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Novavax, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing recombinant protein nanoparticle vaccines and adjuvants. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback